Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice.

Ekanayaka SA, McClellan SA, Peng X, Barrett RP, Francis R, Hazlett LD.

J Ocul Pharmacol Ther. 2018 Nov 8. doi: 10.1089/jop.2018.0073. [Epub ahead of print]

2.

Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.

Ekanayaka SA, McClellan SA, Barrett RP, Hazlett LD.

J Ocul Pharmacol Ther. 2018 Apr;34(3):239-249. doi: 10.1089/jop.2017.0094. Epub 2017 Dec 13.

3.

Characterization of Three Ocular Clinical Isolates of P. aeruginosa: Viability, Biofilm Formation, Adherence, Infectivity, and Effects of Glycyrrhizin.

Peng X, Ekanayaka SA, McClellan SA, Barrett RP, Vistisen K, Hazlett LD.

Pathogens. 2017 Oct 24;6(4). pii: E52. doi: 10.3390/pathogens6040052.

4.

Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.

Ekanayaka SA, McClellan SA, Barrett RP, Kharotia S, Hazlett LD.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5799-5809. doi: 10.1167/iovs.16-20103.

5.

Inactivation of the miR-183/96/182 Cluster Decreases the Severity of Pseudomonas aeruginosa-Induced Keratitis.

Muraleedharan CK, McClellan SA, Barrett RP, Li C, Montenegro D, Carion T, Berger E, Hazlett LD, Xu S.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1506-17. doi: 10.1167/iovs.16-19134.

6.

Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.

McClellan SA, Ekanayaka SA, Li C, Jiang X, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8091-100. doi: 10.1167/iovs.15-18393.

7.

Developmental meta-analysis of the functional neural correlates of autism spectrum disorders.

Dickstein DP, Pescosolido MF, Reidy BL, Galvan T, Kim KL, Seymour KE, Laird AR, Di Martino A, Barrett RP.

J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):279-289.e16. doi: 10.1016/j.jaac.2012.12.012.

8.

The role of VIP in cornea.

Jiang X, McClellan SA, Barrett RP, Zhang Y, Foldenauer ME, Hazlett LD.

Invest Ophthalmol Vis Sci. 2012 Nov 7;53(12):7560-6. doi: 10.1167/iovs.12-10437.

9.

Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis.

Berger EA, Vistisen KS, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 2012 Nov 1;53(12):7432-9. doi: 10.1167/iovs.12-9894.

10.

Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.

Foldenauer ME, McClellan SA, Barrett RP, Zhang Y, Hazlett LD.

Cornea. 2012 Oct;31(10):1176-88. doi: 10.1097/ICO.0b013e31824d6ffd.

11.

Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea.

Jiang X, McClellan SA, Barrett RP, Zhang Y, Hazlett LD.

J Immunol. 2012 Jul 1;189(1):269-78. doi: 10.4049/jimmunol.1200365. Epub 2012 Jun 1.

12.

VIP and growth factors in the infected cornea.

Jiang X, McClellan SA, Barrett RP, Berger EA, Zhang Y, Hazlett LD.

Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6154-61. doi: 10.1167/iovs.10-6943.

13.

Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation.

Berger EA, McClellan SA, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 2011 Jul 18;52(8):5339-46. doi: 10.1167/iovs.10-6920.

14.

VIP promotes resistance in the Pseudomonas aeruginosa-infected cornea by modulating adhesion molecule expression.

Berger EA, McClellan SA, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5776-82. doi: 10.1167/iovs.09-4917. Epub 2010 Jun 30.

15.

Role of the Fas pathway in Pseudomonas aeruginosa keratitis.

Zhou Z, Wu M, Barrett RP, McClellan SA, Zhang Y, Hazlett LD.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2537-47. doi: 10.1167/iovs.09-4152. Epub 2009 Dec 17.

16.

Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis.

Wu M, McClellan SA, Barrett RP, Zhang Y, Hazlett LD.

J Immunol. 2009 Dec 15;183(12):8054-60. doi: 10.4049/jimmunol.0902140.

17.

IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis.

Hazlett LD, McClellan SA, Barrett RP, Huang X, Zhang Y, Wu M, van Rooijen N, Szliter E.

Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1524-32. doi: 10.1167/iovs.09-3983. Epub 2009 Nov 5.

18.

Beta-defensin-2 promotes resistance against infection with P. aeruginosa.

Wu M, McClellan SA, Barrett RP, Hazlett LD.

J Immunol. 2009 Feb 1;182(3):1609-16.

19.

Rat silicone hydrogel contact lens model: effects of high- versus low-Dk lens wear.

Zhang Y, Gabriel MM, Mowrey-McKee MF, Barrett RP, McClellan S, Hazlett LD.

Eye Contact Lens. 2008 Nov;34(6):306-11. doi: 10.1097/ICL.0b013e3181891421.

20.

Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection.

Zhou Z, Barrett RP, McClellan SA, Zhang Y, Szliter EA, van Rooijen N, Hazlett LD.

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4458-67. doi: 10.1167/iovs.08-1906. Epub 2008 Jun 19.

PMID:
18566468
21.

Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.

McClellan SA, Zhang Y, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1502-11. doi: 10.1167/iovs.07-1369.

PMID:
18385069
22.

ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.

Huang X, Du W, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4626-33.

PMID:
17898286
23.

NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice.

Hazlett LD, Li Q, Liu J, McClellan S, Du W, Barrett RP.

J Immunol. 2007 Jul 15;179(2):1138-46.

24.

Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.

Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Lighvani S.

Invest Ophthalmol Vis Sci. 2007 Feb;48(2):797-807.

PMID:
17251480
26.

TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.

Huang X, Du W, McClellan SA, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4910-6.

PMID:
17065506
27.
28.

Pseudomonas aeruginosa-induced inflammation in the rat extended-wear contact lens model.

Szliter EA, Barrett RP, Gabriel MM, Zhang Y, Hazlett LD.

Eye Contact Lens. 2006 Jan;32(1):12-8.

PMID:
16415687
29.

Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.

McClellan SA, Huang X, Barrett RP, Lighvani S, Zhang Y, Richiert D, Hazlett LD.

Invest Ophthalmol Vis Sci. 2006 Jan;47(1):256-64.

PMID:
16384971
30.

Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.

Huang X, Barrett RP, McClellan SA, Hazlett LD.

Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4209-16.

PMID:
16249500
31.

Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury.

Sosne G, Christopherson PL, Barrett RP, Fridman R.

Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2388-95.

PMID:
15980226
32.

Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.

Thakur A, Barrett RP, McClellan S, Hazlett LD.

Curr Eye Res. 2004 Oct-Nov;29(4-5):225-33.

PMID:
15590467
33.

Caspase-1 inhibitor reduces severity of pseudomonas aeruginosa keratitis in mice.

Thakur A, Barrett RP, Hobden JA, Hazlett LD.

Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3177-84.

PMID:
15326138
34.

TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction.

Kernacki KA, Chunta JL, Barrett RP, Hazlett LD.

Exp Eye Res. 2004 Jun;78(6):1155-62.

PMID:
15109922
35.

Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.

Hazlett LD, Huang X, McClellan SA, Barrett RP.

Eye (Lond). 2003 Nov;17(8):863-71.

PMID:
14631390
36.
37.
38.

Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.

Hazlett LD, Rudner XL, McClellan SA, Barrett RP, Lighvani S.

Invest Ophthalmol Vis Sci. 2002 Feb;43(2):419-24.

PMID:
11818386
39.

The role of Langerhans cells in Pseudomonas aeruginosa infection.

Hazlett LD, McClellan SA, Rudner XL, Barrett RP.

Invest Ophthalmol Vis Sci. 2002 Jan;43(1):189-97.

PMID:
11773031
40.

MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection.

Kernacki KA, Barrett RP, McClellan S, Hazlett LD.

J Leukoc Biol. 2001 Dec;70(6):911-9.

PMID:
11739554
41.

Aging and PMN response to P. aeruginosa infection.

Kernacki KA, Barrett RP, McClellan SA, Hazlett LD.

Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3019-25.

PMID:
10967059
43.

Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection.

Kernacki KA, Barrett RP, Hobden JA, Hazlett LD.

J Immunol. 2000 Jan 15;164(2):1037-45.

44.

Complement defects in aged mice compromise phagocytosis of Pseudomonas aeruginosa.

Hazlett LD, Masinick-McClellan SA, Barrett RP.

Curr Eye Res. 1999 Jul;19(1):26-32.

PMID:
10415454
45.

Pseudomonas aeruginosa keratitis in knockout mice deficient in intercellular adhesion molecule 1.

Hobden JA, Masinick-McClellan S, Barrett RP, Bark KS, Hazlett LD.

Infect Immun. 1999 Feb;67(2):972-5.

46.

Experimental neodymium:YAG laser damage to acrylic, poly(methyl methacrylate), and silicone intraocular lens materials.

Newland TJ, McDermott ML, Eliott D, Hazlett LD, Apple DJ, Lambert RJ, Barrett RP.

J Cataract Refract Surg. 1999 Jan;25(1):72-6.

PMID:
9888080
47.

Viscoelastic adherence to corneal endothelium following phacoemulsification.

McDermott ML, Hazlett LD, Barrett RP, Lambert RJ.

J Cataract Refract Surg. 1998 May;24(5):678-83.

PMID:
9610453
48.

Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.

Hobden JA, Masinick SA, Barrett RP, Hazlett LD.

Infect Immun. 1997 Jul;65(7):2754-8.

49.

Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection.

Hobden JA, Masinick SA, Barrett RP, Hazlett LD.

Invest Ophthalmol Vis Sci. 1995 May;36(6):1107-14.

PMID:
7730020
50.

Suicidal behavior in children and adolescents with mental retardation.

Walters AS, Barrett RP, Knapp LG, Borden MC.

Res Dev Disabil. 1995 Mar-Apr;16(2):85-96.

PMID:
7792410

Supplemental Content

Loading ...
Support Center